{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T19:58:31Z","timestamp":1780948711514,"version":"3.54.1"},"reference-count":96,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"DOI":"10.1038\/s41390-026-05150-w","type":"journal-article","created":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T17:50:19Z","timestamp":1780941019000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hyperoxia and pulmonary vascular injury in bronchopulmonary dysplasia: pathogenic mechanisms and emerging therapies\u2014a systematic review"],"prefix":"10.1038","author":[{"given":"Junpeng","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yadi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanting","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbin","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,8]]},"reference":[{"key":"5150_CR1","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1159\/000313024","volume":"99","author":"L Gortner","year":"2011","unstructured":"Gortner, L. et al. Rates of bronchopulmonary dysplasia in very preterm neonates in Europe: results from the MOSAIC cohort. Neonatology 99, 112\u2013117 (2011).","journal-title":"Neonatology"},{"key":"5150_CR2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.18904","volume":"4","author":"Y Cao","year":"2021","unstructured":"Cao, Y. et al. Assessment of neonatal intensive care unit practices, morbidity, and mortality among very preterm infants in China. JAMA Netw. Open 4, e2118904 (2021).","journal-title":"JAMA Netw. Open"},{"key":"5150_CR3","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.jpeds.2020.11.041","volume":"230","author":"T Nakashima","year":"2021","unstructured":"Nakashima, T. et al. Trends in bronchopulmonary dysplasia among extremely preterm infants in Japan, 2003-2016. J. Pediatr. 230, 119\u2013125.e7 (2021).","journal-title":"J. Pediatr."},{"key":"5150_CR4","doi-asserted-by":"publisher","first-page":"F128","DOI":"10.1136\/adc.2003.046268","volume":"90","author":"SR Hintz","year":"2005","unstructured":"Hintz, S. R. et al. Changes in mortality and morbidities among infants born at less than 25 weeks during the post-surfactant era. Arch. Dis. Child Fetal Neonatal Ed. 90, F128\u2013F133 (2005).","journal-title":"Arch. Dis. Child Fetal Neonatal Ed."},{"key":"5150_CR5","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1542\/peds.2004-1497","volume":"115","author":"GMSJ Stoelhorst","year":"2005","unstructured":"Stoelhorst, G. M. S. J. et al. Changes in neonatology: comparison of two cohorts of very preterm infants (gestational age <32 weeks): the project on preterm and small for gestational age infants 1983 and the Leiden follow-up project on prematurity 1996-1997. Pediatrics 115, 396\u2013405 (2005).","journal-title":"Pediatrics"},{"key":"5150_CR6","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1164\/rccm.200908-1190OC","volume":"181","author":"JE Balinotti","year":"2010","unstructured":"Balinotti, J. E. et al. Growth of lung parenchyma in infants and toddlers with chronic lung disease of infancy. Am. J. Respir. Crit. Care Med. 181, 1093\u20131097 (2010).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"5150_CR7","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1136\/thorax.56.4.317","volume":"56","author":"E Eber","year":"2001","unstructured":"Eber, E. et al. Long term sequelae of bronchopulmonary dysplasia (chronic lung disease of infancy). Thorax 56, 317\u2013323 (2001).","journal-title":"Thorax"},{"key":"5150_CR8","doi-asserted-by":"publisher","first-page":"L1036","DOI":"10.1152\/ajplung.00176.2021","volume":"321","author":"S Panahabadi","year":"2021","unstructured":"Panahabadi, S. et al. Increased circulating cytokeratin 19 fragment levels in preterm neonates receiving mechanical ventilation are associated with poor outcome. Am. J. Physiol.-Lung Cell. Mol. Physiol. 321, L1036\u2013L1043 (2021).","journal-title":"Am. J. Physiol.-Lung Cell. Mol. Physiol."},{"key":"5150_CR9","doi-asserted-by":"publisher","first-page":"3803","DOI":"10.1080\/14767058.2019.1689945","volume":"34","author":"L Sarno","year":"2021","unstructured":"Sarno, L. et al. Histological chorioamnionitis and risk of pulmonary complications in preterm births: a systematic review and meta-analysis. J. Matern. Fetal Neonatal Med. 34, 3803\u20133812 (2021).","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"5150_CR10","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1002\/(SICI)1099-0496(199610)22:4<215::AID-PPUL1>3.0.CO;2-L","volume":"22","author":"K Cherukupalli","year":"1996","unstructured":"Cherukupalli, K., Larson, J. E., Rotschild, A. & Thurlbeck, W. M. Biochemical, clinical, and morphologic studies on lungs of infants with bronchopulmonary dysplasia. Pediatr. Pulmonol. 22, 215\u2013229 (1996).","journal-title":"Pediatr. Pulmonol."},{"key":"5150_CR11","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1136\/adc.64.4_Spec_No.448","volume":"64","author":"I Hyde","year":"1989","unstructured":"Hyde, I., English, R. E. & Williams, J. D. The changing pattern of chronic lung disease of prematurity. Arch. Dis. Child. 64, 448\u2013451 (1989).","journal-title":"Arch. Dis. Child."},{"key":"5150_CR12","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1056\/NEJM196702162760701","volume":"276","author":"WH Northway Jr","year":"1967","unstructured":"Northway, W. H. Jr, Rosan, R. C. & Porter, D. Y. Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. N. Engl. J. Med. 276, 357\u2013368 (1967).","journal-title":"N. Engl. J. Med."},{"key":"5150_CR13","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1164\/ajrccm.152.2.7633720","volume":"152","author":"JJ Coalson","year":"1995","unstructured":"Coalson, J. J., Winter, V. & deLemos, R. A. Decreased alveolarization in baboon survivors with bronchopulmonary dysplasia. Am. J. Respir. Crit. Care Med. 152, 640\u2013646 (1995).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"5150_CR14","first-page":"17","volume":"24","author":"JA Voynow","year":"2017","unstructured":"Voynow, J. A. new\u201d bronchopulmonary dysplasia and chronic lung disease. Paediatr. Respir. Rev. 24, 17\u201318 (2017).","journal-title":"Paediatr. Respir. Rev."},{"key":"5150_CR15","doi-asserted-by":"publisher","first-page":"L1101","DOI":"10.1152\/ajplung.00343.2017","volume":"313","author":"DE Surate Solaligue","year":"2017","unstructured":"Surate Solaligue, D. E., Rodr\u00edguez-Castillo, J. A., Ahlbrecht, K. & Morty, R. E. Recent advances in our understanding of the mechanisms of late lung development and bronchopulmonary dysplasia. Am. J. Physiol. Lung Cell. Mol. Physiol. 313, L1101\u2013L1153 (2017).","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"5150_CR16","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1164\/ajrccm.164.10.2109111c","volume":"164","author":"SH Abman","year":"2001","unstructured":"Abman, S. H. Bronchopulmonary dysplasia: \u201ca vascular hypothesis. Am. J. Respir. Crit. Care Med. 164, 1755\u20131756 (2001).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"5150_CR17","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1113\/JP276040","volume":"597","author":"A Sehgal","year":"2019","unstructured":"Sehgal, A. et al. Preterm growth restriction and bronchopulmonary dysplasia: the vascular hypothesis and related physiology. J. Physiol. 597, 1209\u20131220 (2019).","journal-title":"J. Physiol."},{"key":"5150_CR18","doi-asserted-by":"publisher","first-page":"L600","DOI":"10.1152\/ajplung.2000.279.3.L600","volume":"279","author":"M Jakkula","year":"2000","unstructured":"Jakkula, M. et al. Inhibition of angiogenesis decreases alveolarization in the developing rat lung. Am. J. Physiol. Lung Cell. Mol. Physiol. 279, L600\u2013L607 (2000).","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"5150_CR19","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1210\/edrv.18.1.0287","volume":"18","author":"N Ferrara","year":"1997","unstructured":"Ferrara, N. & Davis-Smyth, T. The biology of vascular endothelial growth factor. Endocr. Rev. 18, 4\u201325 (1997).","journal-title":"Endocr. Rev."},{"key":"5150_CR20","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/S0002-9440(10)65329-1","volume":"154","author":"JG Klekamp","year":"1999","unstructured":"Klekamp, J. G., Jarzecka, K. & Perkett, E. A. Exposure to hyperoxia decreases the expression of vascular endothelial growth factor and its receptors in adult rat lungs. Am. J. Pathol. 154, 823\u2013831 (1999).","journal-title":"Am. J. Pathol."},{"key":"5150_CR21","unstructured":"Page, M. J. et al. The PRISMA 2020 statement: an updated guideline for reporting systematicreviews. BMJ 372, n71 (2021)."},{"key":"5150_CR22","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1002\/jrsm.1657","volume":"14","author":"V Paiva Barbosa","year":"2023","unstructured":"Paiva Barbosa, V. et al. Critical appraisal tools used in systematic reviews of in vitro cell culture studies: a methodological study. Res. Synth. Methods 14, 776\u2013793 (2023).","journal-title":"Res. Synth. Methods"},{"key":"5150_CR23","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.prosdent.2022.05.019","volume":"131","author":"VH Sheth","year":"2024","unstructured":"Sheth, V. H. et al. Development and validation of a risk-of-bias tool for assessing in vitro studies conducted in dentistry: The QUIN. J. Prosthet. Dent. 131, 1038\u20131042 (2024).","journal-title":"J. Prosthet. Dent."},{"key":"5150_CR24","unstructured":"Jeremy Howick, et al. \u201cThe 2011 Oxford CEBM Levels of Evidence (Introductory Document)\u201d. Oxford Centre for Evidence - Based Medicine. https:\/\/www.cebm.ox.ac.uk\/resources\/levels-of-evidence\/ocebm-levels-of-evidence"},{"key":"5150_CR25","doi-asserted-by":"publisher","first-page":"e0147588","DOI":"10.1371\/journal.pone.0147588","volume":"11","author":"MA Syed","year":"2016","unstructured":"Syed, M. A., Choo-Wing, R., Homer, R. J. & Bhandari, V. Role of nitric oxide isoforms in vascular and alveolar development and lung injury in vascular endothelial growth factor overexpressing neonatal mice lungs. PLoS ONE 11, e0147588 (2016).","journal-title":"PLoS ONE"},{"key":"5150_CR26","doi-asserted-by":"publisher","first-page":"L1160","DOI":"10.1152\/ajplung.00234.2009","volume":"297","author":"H Fujinaga","year":"2009","unstructured":"Fujinaga, H. et al. Hyperoxia disrupts vascular endothelial growth factor-nitric oxide signaling and decreases growth of endothelial colony-forming cells from preterm infants. Am. J. Physiol. Lung Cell. Mol. Physiol. 297, L1160\u2013L1169 (2009).","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"5150_CR27","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1165\/rcmb.2007-0024OC","volume":"39","author":"V Bhandari","year":"2008","unstructured":"Bhandari, V. et al. Developmental regulation of NO-mediated VEGF-induced effects in the lung. Am. J. Respir. Cell Mol. Biol. 39, 420\u2013430 (2008).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"5150_CR28","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1136\/thoraxjnl-2021-218083","volume":"77","author":"M Heydarian","year":"2022","unstructured":"Heydarian, M. et al. Relationship between impaired BMP signalling and clinical risk factors at early-stage vascular injury in the preterm infant. Thorax 77, 1176\u20131186 (2022).","journal-title":"Thorax"},{"key":"5150_CR29","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1080\/01902148.2016.1226448","volume":"42","author":"M Jin","year":"2016","unstructured":"Jin, M. et al. Alteration of TGF-\u03b2-ALK-smad signaling in hyperoxia-induced bronchopulmonary dysplasia model of newborn rats. Exp. Lung Res. 42, 354\u2013364 (2016).","journal-title":"Exp. Lung Res."},{"key":"5150_CR30","doi-asserted-by":"publisher","first-page":"L299","DOI":"10.1152\/ajplung.00034.2023","volume":"325","author":"S Rao","year":"2023","unstructured":"Rao, S. et al. Endothelial-specific loss of IKK\u03b2 disrupts pulmonary endothelial angiogenesis and impairs postnatal lung growth. Am. J. Physiol. Lung Cell. Mol. Physiol. 325, L299\u2013L313 (2023).","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"5150_CR31","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.3390\/ijms19051525","volume":"19","author":"RT Menon","year":"2018","unstructured":"Menon, R. T., Shrestha, A. K., Barrios, R. & Shivanna, B. Hyperoxia disrupts extracellular signal-regulated kinases 1\/2-induced angiogenesis in the developing lungs. IJMS 19, 1525 (2018).","journal-title":"IJMS"},{"key":"5150_CR32","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.3390\/antiox11061130","volume":"11","author":"RT Menon","year":"2022","unstructured":"Menon, R. T. et al. Extracellular signal-regulated kinase 1 alone is dispensable for hyperoxia-mediated alveolar and pulmonary vascular simplification in neonatal mice. Antioxidants 11, 1130 (2022).","journal-title":"Antioxidants"},{"key":"5150_CR33","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1093\/hmg\/ddy439","volume":"28","author":"C-M Chao","year":"2019","unstructured":"Chao, C.-M. et al. Impact of Fgf10 deficiency on pulmonary vasculature formation in a mouse model of bronchopulmonary dysplasia. Hum. Mol. Genet. 28, 1429\u20131444 (2019).","journal-title":"Hum. Mol. Genet."},{"key":"5150_CR34","doi-asserted-by":"publisher","first-page":"190","DOI":"10.3389\/fped.2020.00190","volume":"8","author":"Y Ruan","year":"2020","unstructured":"Ruan, Y. et al. The changes of Twist1 pathway in pulmonary microvascular permeability in a newborn rat model of hyperoxia-induced acute lung injury. Front. Pediatr. 8, 190 (2020).","journal-title":"Front. Pediatr."},{"key":"5150_CR35","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.182880","volume":"10","author":"L Vila Ellis","year":"2025","unstructured":"Vila Ellis, L. et al. p53 maintains lineage fidelity during lung capillary injury-repair in neonatal hyperoxia. JCI Insight 10, e182880 (2025).","journal-title":"JCI Insight"},{"key":"5150_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1039103","volume":"13","author":"Y Long","year":"2022","unstructured":"Long, Y. et al. Deficiency of endothelial FGFR1 alleviates hyperoxia-induced bronchopulmonary dysplasia in neonatal mice. Front. Pharm. 13, 1039103 (2022).","journal-title":"Front. Pharm."},{"key":"5150_CR37","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.ajpath.2019.11.011","volume":"190","author":"RT Menon","year":"2020","unstructured":"Menon, R. T. et al. Adrenomedullin is necessary to resolve hyperoxia-induced experimental bronchopulmonary dysplasia and pulmonary hypertension in mice. Am. J. Pathol. 190, 711\u2013722 (2020).","journal-title":"Am. J. Pathol."},{"key":"5150_CR38","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1186\/s12931-024-03039-y","volume":"25","author":"X Hu","year":"2024","unstructured":"Hu, X. et al. Knockdown of the long noncoding RNA VSIG2-1:1 promotes the angiogenic ability of human pulmonary microvascular endothelial cells by activating the VEGF\/PI3K\/AKT pathway. Respir. Res. 25, 412 (2024).","journal-title":"Respir. Res."},{"key":"5150_CR39","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1002\/path.5534","volume":"252","author":"J Gong","year":"2020","unstructured":"Gong, J. et al. Endothelial to mesenchymal transition during neonatal hyperoxia-induced pulmonary hypertension. J. Pathol. 252, 411\u2013422 (2020).","journal-title":"J. Pathol."},{"key":"5150_CR40","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202415824","volume":"12","author":"X Li","year":"2025","unstructured":"Li, X. et al. Endothelial Cpt1a inhibits neonatal hyperoxia-induced pulmonary vascular remodeling by repressing endothelial-mesenchymal transition. Adv. Sci. 12, 2415824 (2025).","journal-title":"Adv. Sci."},{"key":"5150_CR41","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1007\/s10753-018-0772-0","volume":"41","author":"J Costa","year":"2018","unstructured":"Costa, J. et al. Inflammatory response of pulmonary artery smooth muscle cells exposed to oxidative and biophysical stress. Inflammation 41, 1250\u20131258 (2018).","journal-title":"Inflammation"},{"key":"5150_CR42","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s10020-023-00770-y","volume":"30","author":"Y Zhu","year":"2024","unstructured":"Zhu, Y. et al. IRF4 affects the protective effect of regulatory T cells on the pulmonary vasculature of a bronchopulmonary dysplasia mouse model by regulating FOXP3. Mol. Med. 30, 6 (2024).","journal-title":"Mol. Med."},{"key":"5150_CR43","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.137594","volume":"6","author":"J Gong","year":"2021","unstructured":"Gong, J. et al. The pentose phosphate pathway mediates hyperoxia-induced lung vascular dysgenesis and alveolar simplification in neonates. JCI Insight 6, e137594 (2021).","journal-title":"JCI Insight"},{"key":"5150_CR44","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.3390\/antiox10121913","volume":"10","author":"A Elsaie","year":"2021","unstructured":"Elsaie, A. et al. Endothelial adenosine monophosphate-activated protein kinase-Alpha1 deficiency potentiates hyperoxia-induced experimental bronchopulmonary dysplasia and pulmonary hypertension. Antioxidants 10, 1913 (2021).","journal-title":"Antioxidants"},{"key":"5150_CR45","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1164\/rccm.200711-1631OC","volume":"178","author":"GJ Rey-Parra","year":"2008","unstructured":"Rey-Parra, G. J. et al. Blunted hypoxic pulmonary vasoconstriction in experimental neonatal chronic lung disease. Am. J. Respir. Crit. Care Med. 178, 399\u2013406 (2008).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"5150_CR46","doi-asserted-by":"publisher","first-page":"e0173044","DOI":"10.1371\/journal.pone.0173044","volume":"12","author":"E Dumas De La Roque","year":"2017","unstructured":"Dumas De La Roque, E. et al. Altered vasoreactivity in neonatal rats with pulmonary hypertension associated with bronchopulmonary dysplasia: implication of both eNOS phosphorylation and calcium signaling. PLoS ONE 12, e0173044 (2017).","journal-title":"PLoS ONE"},{"key":"5150_CR47","doi-asserted-by":"publisher","first-page":"e0180957","DOI":"10.1371\/journal.pone.0180957","volume":"12","author":"M Perez","year":"2017","unstructured":"Perez, M. et al. Aberrant cGMP signaling persists during recovery in mice with oxygen-induced pulmonary hypertension. PLoS ONE 12, e0180957 (2017).","journal-title":"PLoS ONE"},{"key":"5150_CR48","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3892\/mmr.2014.2192","volume":"10","author":"C Li","year":"2014","unstructured":"Li, C. et al. Hyperoxia arrests pulmonary development in newborn rats via disruption of endothelial tight junctions and downregulation of Cx40. Mol. Med. Rep. 10, 61\u201367 (2014).","journal-title":"Mol. Med. Rep."},{"key":"5150_CR49","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1016\/j.ajpath.2011.02.010","volume":"178","author":"M Yee","year":"2011","unstructured":"Yee, M. et al. Neonatal hyperoxia causes pulmonary vascular disease and shortens life span in aging mice. Am. J. Pathol. 178, 2601\u20132610 (2011).","journal-title":"Am. J. Pathol."},{"key":"5150_CR50","doi-asserted-by":"publisher","first-page":"L846","DOI":"10.1152\/ajplung.00409.2017","volume":"314","author":"M Yee","year":"2018","unstructured":"Yee, M. et al. Neonatal hyperoxia depletes pulmonary vein cardiomyocytes in adult mice via mitochondrial oxidation. Am. J. Physiol. Lung Cell. Mol. Physiol. 314, L846\u2013L859 (2018).","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"5150_CR51","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1080\/14767058.2018.1541081","volume":"33","author":"C Revhaug","year":"2020","unstructured":"Revhaug, C. et al. Pulmonary vascular disease is evident in gene regulation of experimental bronchopulmonary dysplasia. J. Matern. Fetal Neonatal Med. 33, 2122\u20132130 (2020).","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"5150_CR52","first-page":"4553","volume":"28","author":"L Wang","year":"2017","unstructured":"Wang, L. et al. Expression of vascular endothelial growth factor and angiopoietin-1 in postnatal rats with hyperoxia-induced lung injury and its effect on pulmonary development. Biomed. Res. 28, 4553\u20134557 (2017).","journal-title":"Biomed. Res."},{"key":"5150_CR53","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1111\/1440-1681.12909","volume":"45","author":"JK Trittmann","year":"2018","unstructured":"Trittmann, J. K. et al. Arginase and \u03b1-smooth muscle actin induction after hyperoxic exposure in a mouse model of bronchopulmonary dysplasia. Clin. Exp. Pharmacol. Physiol. 45, 556\u2013562 (2018).","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"5150_CR54","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.niox.2020.12.002","volume":"107","author":"E Lignelli","year":"2021","unstructured":"Lignelli, E. et al. The H2S-generating enzyme 3-mercaptopyruvate sulfurtransferase regulates pulmonary vascular smooth muscle cell migration and proliferation but does not impact normal or aberrant lung development. Nitric Oxide 107, 31\u201345 (2021).","journal-title":"Nitric Oxide"},{"key":"5150_CR55","doi-asserted-by":"publisher","first-page":"L716","DOI":"10.1152\/ajplung.00381.2024","volume":"328","author":"M Mathias","year":"2025","unstructured":"Mathias, M. et al. Selenium modulates perinatal pulmonary vascular responses to hyperoxia. Am. J. Physiol. Lung Cell. Mol. Physiol. 328, L716\u2013L723 (2025).","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"5150_CR56","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.freeradbiomed.2008.12.008","volume":"46","author":"V Sampath","year":"2009","unstructured":"Sampath, V. et al. Attenuation of lipopolysaccharide-induced oxidative stress and apoptosis in fetal pulmonary artery endothelial cells by hypoxia. Free Radic. Biol. Med. 46, 663\u2013671 (2009).","journal-title":"Free Radic. Biol. Med."},{"key":"5150_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2024.177120","volume":"985","author":"X Chen","year":"2024","unstructured":"Chen, X. et al. Inhibition of lysophosphatidic acid receptor 2 attenuates neonatal chronic lung disease in mice by preserving vascular and alveolar development. Eur. J. Pharmacol. 985, 177120 (2024).","journal-title":"Eur. J. Pharmacol."},{"key":"5150_CR58","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s12890-019-0903-x","volume":"19","author":"V Dumpa","year":"2019","unstructured":"Dumpa, V., Nielsen, L., Wang, H. & Kumar, V. H. S. Caffeine is associated with improved alveolarization and angiogenesis in male mice following hyperoxia induced lung injury. BMC Pulm. Med. 19, 138 (2019).","journal-title":"BMC Pulm. Med."},{"key":"5150_CR59","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3349\/ymj.2014.55.1.99","volume":"55","author":"HJ Lee","year":"2014","unstructured":"Lee, H. J. et al. Rosiglitazone, a peroxisome proliferator-activated receptor-\u03b3 agonist, restores alveolar and pulmonary vascular development in a rat model of bronchopulmonary dysplasia. Yonsei Med. J. 55, 99 (2014).","journal-title":"Yonsei Med. J."},{"key":"5150_CR60","first-page":"6092","volume":"12","author":"X Xiang","year":"2020","unstructured":"Xiang, X., Wang, L., Zhou, L., Chen, Y. & Xia, H. Metformin upregulates the expression of Gli1 in vascular endothelial cells in hyperoxia-exposed neonatal mice. Am. J. Transl. Res. 12, 6092\u20136106 (2020).","journal-title":"Am. J. Transl. Res."},{"key":"5150_CR61","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1002\/iub.2588","volume":"74","author":"X Xiang","year":"2022","unstructured":"Xiang, X. et al. Metformin regulates macrophage polarization via the shh signaling pathway to improve pulmonary vascular development in bronchopulmonary dysplasia. IUBMB Life 74, 259\u2013271 (2022).","journal-title":"IUBMB Life"},{"key":"5150_CR62","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/pr.2016.52","volume":"80","author":"M Rong","year":"2016","unstructured":"Rong, M. et al. Inhibition of \u03b2-catenin signaling protects against CTGF-induced alveolar and vascular pathology in neonatal mouse lung. Pediatr. Res. 80, 136\u2013144 (2016).","journal-title":"Pediatr. Res."},{"key":"5150_CR63","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1093\/toxsci\/kfv183","volume":"148","author":"B Shivanna","year":"2015","unstructured":"Shivanna, B. et al. Omeprazole attenuates pulmonary aryl hydrocarbon receptor activation and potentiates hyperoxia-induced developmental lung injury in newborn mice. Toxicol. Sci. 148, 276\u2013287 (2015).","journal-title":"Toxicol. Sci."},{"key":"5150_CR64","doi-asserted-by":"publisher","first-page":"424","DOI":"10.4172\/2153-2435.1000424","volume":"6","author":"A Patel","year":"2015","unstructured":"Patel, A., Zhang, S. & Moorthy, B. Omeprazole does not potentiate acute oxygen toxicity in fetal human pulmonary microvascular endothelial cells exposed to hyperoxia. Pharm. Anal. Acta 6, 424 (2015).","journal-title":"Pharm. Anal. Acta"},{"key":"5150_CR65","doi-asserted-by":"publisher","first-page":"117881","DOI":"10.1016\/j.biopha.2025.117881","volume":"184","author":"C-M Pilard","year":"2025","unstructured":"Pilard, C.-M. et al. Celastrol has beneficial effects on pulmonary hypertension associated with bronchopulmonary dysplasia: Preclinical study outcomes. Biomed. Pharmacother. 184, 117881 (2025).","journal-title":"Biomed. Pharmacother."},{"key":"5150_CR66","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1164\/rccm.200503-510OC","volume":"172","author":"F Ladha","year":"2005","unstructured":"Ladha, F. et al. Sildenafil improves alveolar growth and pulmonary hypertension in hyperoxia-induced lung injury. Am. J. Respir. Crit. Care Med. 172, 750\u2013756 (2005).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"5150_CR67","doi-asserted-by":"publisher","first-page":"H1575","DOI":"10.1152\/ajpheart.00569.2014","volume":"308","author":"RP Heilman","year":"2015","unstructured":"Heilman, R. P. et al. Right ventricular cyclic nucleotide signaling is decreased in hyperoxia-induced pulmonary hypertension in neonatal mice. Am. J. Physiol.-Heart Circ. Physiol. 308, H1575\u2013H1582 (2015).","journal-title":"Am. J. Physiol.-Heart Circ. Physiol."},{"key":"5150_CR68","doi-asserted-by":"publisher","first-page":"L264","DOI":"10.1152\/ajplung.00073.2012","volume":"304","author":"GTM Wagenaar","year":"2013","unstructured":"Wagenaar, G. T. M. et al. Ambrisentan reduces pulmonary arterial hypertension but does not stimulate alveolar and vascular development in neonatal rats with hyperoxic lung injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 304, L264\u2013L275 (2013).","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"5150_CR69","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2020.619853","volume":"8","author":"Y Dai","year":"2021","unstructured":"Dai, Y. et al. Mitochondrial fission-mediated lung development in newborn rats with hyperoxia-induced bronchopulmonary dysplasia with pulmonary hypertension. Front. Pediatr. 8, 619853 (2021).","journal-title":"Front. Pediatr."},{"key":"5150_CR70","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.3346\/jkms.2015.30.9.1295","volume":"30","author":"CW Choi","year":"2015","unstructured":"Choi, C. W. et al. Deferoxamine improves alveolar and pulmonary vascular development by upregulating hypoxia-inducible factor-1\u03b1 in a rat model of bronchopulmonary dysplasia. J. Korean Med. Sci. 30, 1295 (2015).","journal-title":"J. Korean Med. Sci."},{"key":"5150_CR71","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1016\/j.freeradbiomed.2010.07.001","volume":"49","author":"A Masood","year":"2010","unstructured":"Masood, A. et al. A peroxynitrite decomposition catalyst prevents 60% O2-mediated rat chronic neonatal lung injury. Free Radic. Biol. Med. 49, 1182\u20131191 (2010).","journal-title":"Free Radic. Biol. Med."},{"key":"5150_CR72","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/pr.2016.1","volume":"79","author":"M Perez","year":"2016","unstructured":"Perez, M. et al. Dose-dependent effects of glucocorticoids on pulmonary vascular development in a murine model of hyperoxic lung injury. Pediatr. Res. 79, 759\u2013765 (2016).","journal-title":"Pediatr. Res."},{"key":"5150_CR73","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1164\/rccm.200902-0179OC","volume":"180","author":"T Van Haaften","year":"2009","unstructured":"Van Haaften, T. et al. Airway delivery of mesenchymal stem cells prevents arrested alveolar growth in neonatal lung injury in rats. Am. J. Respir. Crit. Care Med. 180, 1131\u20131142 (2009).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"5150_CR74","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1136\/thoraxjnl-2012-202323","volume":"68","author":"M Pierro","year":"2013","unstructured":"Pierro, M. et al. Short-term, long-term and paracrine effect of human umbilical cord-derived stem cells in lung injury prevention and repair in experimental bronchopulmonary dysplasia. Thorax 68, 475\u2013484 (2013).","journal-title":"Thorax"},{"key":"5150_CR75","doi-asserted-by":"publisher","first-page":"869","DOI":"10.3727\/096368909X471189","volume":"18","author":"YS Chang","year":"2009","unstructured":"Chang, Y. S. et al. Human umbilical cord blood-derived mesenchymal stem cells attenuate hyperoxia-induced lung injury in neonatal rats. Cell Transpl. 18, 869\u2013886 (2009).","journal-title":"Cell Transpl."},{"key":"5150_CR76","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1038\/pr.2015.39","volume":"77","author":"A Lu","year":"2015","unstructured":"Lu, A., Sun, B. & Qian, L. Combined iNO and endothelial progenitor cells improve lung alveolar and vascular structure in neonatal rats exposed to prolonged hyperoxia. Pediatr. Res. 77, 784\u2013792 (2015).","journal-title":"Pediatr. Res."},{"key":"5150_CR77","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1164\/rccm.201705-0925OC","volume":"197","author":"GR Willis","year":"2018","unstructured":"Willis, G. R. et al. Mesenchymal stromal cell exosomes ameliorate experimental bronchopulmonary dysplasia and restore lung function through macrophage immunomodulation. Am. J. Respir. Crit. Care Med. 197, 104\u2013116 (2018).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"5150_CR78","first-page":"1","volume":"50","author":"SY Ahn","year":"2018","unstructured":"Ahn, S. Y. et al. Vascular endothelial growth factor mediates the therapeutic efficacy of mesenchymal stem cell-derived extracellular vesicles against neonatal hyperoxic lung injury. Exp. Mol. Med. 50, 1\u201312 (2018).","journal-title":"Exp. Mol. Med."},{"key":"5150_CR79","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s00408-012-9382-z","volume":"190","author":"D Grisafi","year":"2012","unstructured":"Grisafi, D. et al. L-citrulline prevents alveolar and vascular derangement in a rat model of moderate hyperoxia-induced lung injury. Lung 190, 419\u2013430 (2012).","journal-title":"Lung"},{"key":"5150_CR80","doi-asserted-by":"publisher","first-page":"L116","DOI":"10.1152\/ajplung.00527.2017","volume":"315","author":"Y Zhong","year":"2018","unstructured":"Zhong, Y. et al. Maternal omega-3 PUFA supplementation prevents hyperoxia-induced pulmonary hypertension in the offspring. Am. J. Physiol. Lung Cell. Mol. Physiol. 315, L116\u2013L132 (2018).","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"5150_CR81","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1657823","volume":"16","author":"W Li","year":"2025","unstructured":"Li, W. et al. Decoding STAT3: a new frontier in understanding and treating hyperoxic lung injury. Front. Immunol. 16, 1657823 (2025).","journal-title":"Front. Immunol."},{"key":"5150_CR82","doi-asserted-by":"publisher","first-page":"H1103","DOI":"10.1152\/ajpheart.00580.2021","volume":"321","author":"V Vellingiri","year":"2021","unstructured":"Vellingiri, V. & Mehta, D. TERTing the hyperoxic lung. Am. J. Physiol. Heart Circ. Physiol. 321, H1103\u2013H1105 (2021).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"5150_CR83","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/pr.2016.201","volume":"81","author":"CL Day","year":"2017","unstructured":"Day, C. L. & Ryan, R. M. Bronchopulmonary dysplasia: new becomes old again!. Pediatr. Res. 81, 210\u2013213 (2017).","journal-title":"Pediatr. Res."},{"key":"5150_CR84","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1159\/000371835","volume":"107","author":"S Drummond","year":"2015","unstructured":"Drummond, S. et al. CXCR4 blockade attenuates hyperoxia-induced lung injury in neonatal rats. Neonatology 107, 304\u2013311 (2015).","journal-title":"Neonatology"},{"key":"5150_CR85","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0046-8177(85)80113-1","volume":"16","author":"CA McKay","year":"1985","unstructured":"McKay, C. A., Faulkner, C. S. & Edwards, W. H. Unusual pulmonary reaction to respiratory therapy in a premature newborn. Hum. Pathol. 16, 629\u2013631 (1985).","journal-title":"Hum. Pathol."},{"key":"5150_CR86","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.58843","volume":"8","author":"M Baczynski","year":"2025","unstructured":"Baczynski, M. et al. Response to inhaled nitric oxide and mortality among very preterm neonates with pulmonary hypertension. JAMA Netw. Open 8, e2458843 (2025).","journal-title":"JAMA Netw. Open"},{"key":"5150_CR87","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/S0022-3468(00)90207-0","volume":"35","author":"RJ Jackson","year":"2000","unstructured":"Jackson, R. J. et al. A comparison of neonatal and adult multiorgan failure in a rat model. J. Pediatr. Surg. 35, 428\u2013431 (2000).","journal-title":"J. Pediatr. Surg."},{"key":"5150_CR88","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2012\/295389","volume":"2012","author":"HC Kinney","year":"2012","unstructured":"Kinney, H. C. & Volpe, J. J. Modeling the encephalopathy of prematurity in animals: the important role of translational research. Neurol. Res. Int. 2012, 1\u201317 (2012).","journal-title":"Neurol. Res. Int."},{"key":"5150_CR89","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1177\/1933719115604729","volume":"23","author":"BW Nielsen","year":"2016","unstructured":"Nielsen, B. W. et al. A cross-species analysis of animal models for the investigation of preterm birth mechanisms. Reprod. Sci. 23, 482\u2013491 (2016).","journal-title":"Reprod. Sci."},{"key":"5150_CR90","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1159\/000524438","volume":"119","author":"U Jhaveri Sanghvi","year":"2022","unstructured":"Jhaveri Sanghvi, U., Wright, C. J. & Hernandez, T. L. Pulmonary resilience: moderating the association between oxygen exposure and pulmonary outcomes in extremely preterm newborns. Neonatology 119, 433\u2013442 (2022).","journal-title":"Neonatology"},{"key":"5150_CR91","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1056\/NEJMoa1514212","volume":"374","author":"The BOOST-II Australia and United Kingdom Collaborative Groups","year":"2016","unstructured":"The BOOST-II Australia and United Kingdom Collaborative Groups Outcomes of two trials of oxygen-saturation targets in preterm infants. N. Engl. J. Med. 374, 749\u2013760 (2016).","journal-title":"N. Engl. J. Med."},{"key":"5150_CR92","doi-asserted-by":"publisher","first-page":"dmm047753","DOI":"10.1242\/dmm.047753","volume":"14","author":"K Giusto","year":"2021","unstructured":"Giusto, K., Wanczyk, H., Jensen, T. & Finck, C. Hyperoxia-induced bronchopulmonary dysplasia: better models for better therapies. Dis. Models Mech. 14, dmm047753 (2021).","journal-title":"Dis. Models Mech."},{"key":"5150_CR93","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/S2352-4642(25)00106-3","volume":"9","author":"D De Luca","year":"2025","unstructured":"De Luca, D. et al. The lancet child & adolescent health commission on the future of neonatology. Lancet Child Adolesc. Health 9, 578\u2013612 (2025).","journal-title":"Lancet Child Adolesc. Health"},{"key":"5150_CR94","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1038\/s41390-022-02002-1","volume":"92","author":"A El Saie","year":"2022","unstructured":"El Saie, A. et al. Metabolome and microbiome multi-omics integration from a murine lung inflammation model of bronchopulmonary dysplasia. Pediatr. Res. 92, 1580\u20131589 (2022).","journal-title":"Pediatr. Res."},{"key":"5150_CR95","doi-asserted-by":"publisher","DOI":"10.1016\/j.scr.2023.103301","volume":"74","author":"S Sandelin","year":"2024","unstructured":"Sandelin, S., Hakala, S., Lehtinen, L. & N\u00e4rv\u00e4, E. Generation of three isogenic human induced pluripotent stem cell lines from normal neonate skin fibroblasts. Stem Cell Res. 74, 103301 (2024).","journal-title":"Stem Cell Res."},{"key":"5150_CR96","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/j.1749-0774.2010.00091.x","volume":"23","author":"T Fujioka","year":"2010","unstructured":"Fujioka, T. et al. Establishment of induced pluripotent stem cells from human neonatal tissues: IPS cells derived from neonatal tissues. Hum. Cell 23, 113\u2013118 (2010).","journal-title":"Hum. Cell"}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41390-026-05150-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-026-05150-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-026-05150-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T19:02:21Z","timestamp":1780945341000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-026-05150-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,8]]},"references-count":96,"alternative-id":["5150"],"URL":"https:\/\/doi.org\/10.1038\/s41390-026-05150-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.22541\/au.176296520.00664820\/v1","asserted-by":"object"}]},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,8]]},"assertion":[{"value":"17 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"No large language tools were used.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Instructions for Using Large Language Models"}},{"value":"This study is a systematic review of previously published literature and does not involve any direct contact with human or animal subjects, or the collection of new primary data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}